Cerenome, Inc.
NASDAQTotal Valuation
Cerenome, Inc. carries a market capitalization of 11.01M, placing it among publicly traded companies globally. Its enterprise value stands at -8.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.01M |
| Enterprise Value | -8.54M |
Share Statistics
Cerenome, Inc. currently has 7.31M shares outstanding.
| Shares Outstanding | 7.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cerenome, Inc. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.81, indicating moderate leverage, while an interest coverage ratio of -8.42 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.37 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | -8.42 |
Financial Efficiency
| Return on Equity (ROE) | -614.05 |
| Return on Assets (ROA) | -214.01 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Cerenome, Inc.'s stock has declined approximately -60.49383% over the past 52 weeks. The 50-day moving average sits at 2.93, while the 200-day moving average is 5.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60.49383% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 5.89 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -25.94M, while operating income came in at -26.40M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -26.40M |
| Pretax Income | -26.09M |
| Net Income | -26.09M |
| EBITDA | -25.94M |
| EBIT | -26.40M |
| Earnings Per Share (EPS) | -4.39 |
Balance Sheet
Cerenome, Inc. holds 8.59M in cash and equivalents against 44,000.00 in total debt, resulting in a net debt position of -2.37M. Total book value stands at 5.46M, with working capital of 3.20M providing operational flexibility.
| Cash & Cash Equivalents | 8.59M |
| Total Debt | 44,000.00 |
| Net Debt | -2.37M |
| Equity (Book Value) | 5.46M |
| Book Value Per Share | 0.75 |
| Working Capital | 3.20M |
Cash Flow
Cerenome, Inc. produced -22.17M in operating cash flow over the past twelve months. After subtracting -1.37M in capital expenditures, free cash flow totaled -23.55M - equivalent to -3.96 per share.
| Operating Cash Flow | -22.17M |
| Capital Expenditures | -1.37M |
| Free Cash Flow | -23.55M |
| FCF Per Share | -3.96 |
Scores
Cerenome, Inc. posts an Altman Z-Score of -61.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -61.81 |